Beatrix Grubeck-Loebenstein
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Beatrix Grubeck-Loebenstein has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Birgit Weinberger
Institute for Biomedical Aging Research, Universität Innsbruck
3 shared publications Dietmar Herndler-Brandstetter
Austrian Acad Sci, Inst Biomed Aging Res, A-6020 Innsbruck, Austria
3 shared publicationsI. Blasko
3 shared publicationsMichael Keller
Austrian Academy of Sciences
3 shared publicationsBrigitte Jenewein
Austrian Academy of Sciences
2 shared publicationsE. Steiner
Department of Surgery ‘Bezirkskrankenhaus’ Hall Austria
2 shared publications
Latest Publications
- 1 October 2012
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 18 (s5) , 100-108
Vaccines for the elderly
- 1 October 2012
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 18 (s5) , 100-108
Vaccines for the elderly
- 1 January 2012
- Published by S. Karger AG in Transfusion Medicine and Hemotherapy
- Vol. 39 (5) , 299-300
What Is Aging?
- 1 January 2012
- Published by S. Karger AG in Transfusion Medicine and Hemotherapy
- Vol. 39 (5) , 299-300
What Is Aging?
- 1 January 2010
- Published by Elsevier in Journal of Comparative Pathology
- Vol. 142, S116-S119
Fading Immune Protection in Old Age: Vaccination in the Elderly
- 1 January 2010
- Published by Elsevier in Journal of Comparative Pathology
- Vol. 142, S116-S119
Fading Immune Protection in Old Age: Vaccination in the Elderly
- 1 December 2009
- Published by Elsevier in Immunology Letters
- Vol. 127 (1) , 27-32
CD28−CD8+ T cells do not contain unique clonotypes and are therefore dispensable
- 1 December 2009
- Published by Elsevier in Immunology Letters
- Vol. 127 (1) , 27-32
CD28−CD8+ T cells do not contain unique clonotypes and are therefore dispensable
- 1 June 2009
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 21 (3) , 201-209
Immunosenescence and vaccine failure in the elderly
An age-related decline in immune responses in the elderly results in greater susceptibility to infection and reduced responses to vaccination. This decline in immune function affects both innate and adaptive immune systems. A meeting of experts in immunology and gerontology in Paris, France, in April 2008, considered current understanding of immunosenescence and its clinical consequences. Essential features of immunosenescence include: reduced natural killer cell cytotoxicity on a per cell basis; reduced number and function of dendritic cells in blood; decreased pools of naive T and B cells; and increases in the number of memory and effector T and B cells. In particular, an accumulation of late differentiated effector T cells, commonly associated with cytomegalovirus infection, contributes to a decline in the capacity of the adaptive immune system to respond to novel antigens. Consequently, vaccine responsiveness is compromised in the elderly, especially frail patients. Strategies to address the effects of immunosenescence include ensuring that seroprotective antibody levels against preventable infectious diseases are maintained throughout adulthood, and improving diet and exercise to address the effects of frailty. New vaccines are being developed, such as intradermal and high-dose vaccines for influenza, to improve the efficacy of immunization in the elderly. In the future, the development and use of markers of immunosenescence to identify patients who may have impaired responses to vaccination, as well as the use of end-points other than antibody titers to assess vaccine efficacy, may help to reduce morbidity and mortality due to infections in the elderly.
- 1 June 2009
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 21 (3) , 201-209
Immunosenescence and vaccine failure in the elderly
An age-related decline in immune responses in the elderly results in greater susceptibility to infection and reduced responses to vaccination. This decline in immune function affects both innate and adaptive immune systems. A meeting of experts in immunology and gerontology in Paris, France, in April 2008, considered current understanding of immunosenescence and its clinical consequences. Essential features of immunosenescence include: reduced natural killer cell cytotoxicity on a per cell basis; reduced number and function of dendritic cells in blood; decreased pools of naive T and B cells; and increases in the number of memory and effector T and B cells. In particular, an accumulation of late differentiated effector T cells, commonly associated with cytomegalovirus infection, contributes to a decline in the capacity of the adaptive immune system to respond to novel antigens. Consequently, vaccine responsiveness is compromised in the elderly, especially frail patients. Strategies to address the effects of immunosenescence include ensuring that seroprotective antibody levels against preventable infectious diseases are maintained throughout adulthood, and improving diet and exercise to address the effects of frailty. New vaccines are being developed, such as intradermal and high-dose vaccines for influenza, to improve the efficacy of immunization in the elderly. In the future, the development and use of markers of immunosenescence to identify patients who may have impaired responses to vaccination, as well as the use of end-points other than antibody titers to assess vaccine efficacy, may help to reduce morbidity and mortality due to infections in the elderly.
- Open Access
- 12 November 2008
- Published by Springer Nature in Immunity & Ageing
- Vol. 5 (1) , 14
Age-related appearance of a CMV-specific high-avidity CD8+ T cell clonotype which does not occur in young adults
Old age is associated with characteristic changes of the immune system contributing to higher incidence and severity of many infectious diseases. Particularly within the T cell compartment latent infection with human Cytomegalovirus (CMV) is contributing to and accelerating immunosenescence. However, latent CMV infection and reactivation usually does not cause overt symptoms in immunocompetent elderly persons indicating immunological control of disease. Little is still known about the clonal composition of CMV-specific T cell responses in donors of different age. We therefore analyzed CD8+T cells specific for an immunodominant pp65-derived nonamer-peptide (NLVPMVATV; CMVNLV) in different age-groups. Independent of donor age CMVNLV-specific CD8+T cells preferentially use the V beta family 8. This family has monoclonal expansions in the majority of donors after stimulation of CD8+T cells with the peptide. By sequencing the CDR3 region of the T cell receptor we demonstrated that CMVNLV-specific, BV8+CD8+T cells share the conserved CDR3-sequence motif SANYGYT in donors of all age groups. Interestingly, a second conserved clonotype with the CDR3-sequence motif SVNEAF appears in middle-aged and elderly donors. This clonotype is absent in young individuals. The age-related clonotype SVNEAF binds to the pMHC-complex with higher avidity than the clonotype SANYGYT, which is predominant in young adults. The dominance of this high avidity clonotype may explain the lack of overt CMV-disease in old age.
- 12 November 2008
- Published by Springer Nature in Immunity & Ageing
- Vol. 5 (1) , 14
Open AccessAge-related appearance of a CMV-specific high-avidity CD8+ T cell clonotype which does not occur in young adults
Old age is associated with characteristic changes of the immune system contributing to higher incidence and severity of many infectious diseases. Particularly within the T cell compartment latent infection with human Cytomegalovirus (CMV) is contributing to and accelerating immunosenescence. However, latent CMV infection and reactivation usually does not cause overt symptoms in immunocompetent elderly persons indicating immunological control of disease. Little is still known about the clonal composition of CMV-specific T cell responses in donors of different age. We therefore analyzed CD8+T cells specific for an immunodominant pp65-derived nonamer-peptide (NLVPMVATV; CMVNLV) in different age-groups. Independent of donor age CMVNLV-specific CD8+T cells preferentially use the V beta family 8. This family has monoclonal expansions in the majority of donors after stimulation of CD8+T cells with the peptide. By sequencing the CDR3 region of the T cell receptor we demonstrated that CMVNLV-specific, BV8+CD8+T cells share the conserved CDR3-sequence motif SANYGYT in donors of all age groups. Interestingly, a second conserved clonotype with the CDR3-sequence motif SVNEAF appears in middle-aged and elderly donors. This clonotype is absent in young individuals. The age-related clonotype SVNEAF binds to the pMHC-complex with higher avidity than the clonotype SANYGYT, which is predominant in young adults. The dominance of this high avidity clonotype may explain the lack of overt CMV-disease in old age.
- Open Access
- 11 December 2007
- Published by Springer Nature in Immunity & Ageing
- Vol. 4 (1) , 9
Challenges for vaccination in the elderly
The increased susceptibility of the elderly to infection presents a major challenge to public health services. An aging immune system is well documented as the cause of increased infection rates in elderly people. Such immunosenescence is multi-factorial and incompletely understood. Immunosenescent changes include malfunctioning of innate immune system cellular receptors; involution of the thymus, with consequent reduction of the naïve T cell population; alteration of the T cell population composition; modified phenotypes of individual T cells; and replicative senescence of memory cells expressing naïve markers. Unfortunately, immunosenescence also renders vaccination less effective in the elderly. It is therefore important that the vaccines used against common but preventable diseases, such as influenza, are specifically enhanced to overcome the reduced immune responsiveness of this vulnerable population.
- 11 December 2007
- Published by Springer Nature in Immunity & Ageing
- Vol. 4 (1) , 9
Open AccessChallenges for vaccination in the elderly
The increased susceptibility of the elderly to infection presents a major challenge to public health services. An aging immune system is well documented as the cause of increased infection rates in elderly people. Such immunosenescence is multi-factorial and incompletely understood. Immunosenescent changes include malfunctioning of innate immune system cellular receptors; involution of the thymus, with consequent reduction of the naïve T cell population; alteration of the T cell population composition; modified phenotypes of individual T cells; and replicative senescence of memory cells expressing naïve markers. Unfortunately, immunosenescence also renders vaccination less effective in the elderly. It is therefore important that the vaccines used against common but preventable diseases, such as influenza, are specifically enhanced to overcome the reduced immune responsiveness of this vulnerable population.
- 1 March 2007
- Published by Springer Nature in Wiener Medizinische Wochenschrift
- Vol. 157 (5-6) , 116-121
Immundominante Peptide von konservierten Influenzaproteinen – Eine Möglichkeit für eine wirksamere Impfung älterer Personen?
Influenza-specific CD8+ T cells are important for the clearance of infection especially in high risk groups such as elderly persons. Activation of these cells by immunization might therefore be a useful tool for a better protection of this specific age group. We therefore analyzed the frequency, phenotype and function of CD8+ T cells with specificity to the influenza M158–66 peptide in young, middle-aged and elderly persons ex vivo and after in vitro stimulation. Significantly lower numbers of M158–66-specific CD8+ T cells were detected in the middle-aged and elderly compared to young donors. M158–66-specific CD8+ T cells were either CD45RAlowCD45ROlow or CD45RA-CD45RO+, expressed CD28 and CD62L and did not produce perforin. There was no difference in the phenotype of influenza-specific CD8+ T cells between the three age groups. Despite the initially low numbers of M158–66-specific CD8+ T cells in the older age groups, these cells could be expanded in vitro following peptide stimulation. They also acquired a CD45RO+CD28+ CD62L+/− phenotype and produced perforin. Our results demonstrate that although initially low in number, M158–66-specific CD8+ T cells from elderly persons can be propagated and differentiated into perforin producing effector cells upon appropriate stimulation. M158–66 peptide or other immunodominant peptides derived from conserved influenza proteins could therefore be useful in future influenza vaccines in order to render elderly persons better protected against disease, in particular in the case of an influenza pandemia. Influenza-spezifische zytotoxische CD8+ T-Zellen stellen einen wesentlichen Bestandteil bei der Überwindung einer Infektion dar, insbesondere in Hochrisikogruppen wie älteren Personen. Eine Aktivierung dieser Zellen durch eine Impfung wäre deshalb eine wichtige Voraussetzung um einen besseren Schutz für diese Altersgruppe zu erreichen. Deshalb haben wir die Häufigkeit, den Phänotyp und die Funktion von Influenza M158–66 Peptid-spezifischen CD8+ T-Zellen in drei verschiedenen Altersgruppen (27 ± 1 Jahre; 46 ± 3 Jahre und 72 ± 2 Jahre) ex vivo und nach in vitro Stimulation untersucht. Bei Personen ab einem Alter von 38 Jahren stellten wir eine geringere Anzahl von M158–66-spezifischen CD8+ T-Zellen fest. Diese Zellen exprimierten CD28, CD62L und waren entweder CD45RAlowCD45ROlow oder CD45RA-CD45RO+, produzierten aber kein Perforin. Kein Unterschied zeigte sich beim Phänotyp von Influenza-spezifischen CD8+ T-Zellen zwischen den drei Altersgruppen. Trotz der zu Beginn geringen Anzahl von M158–66-spezifischen CD8+ T-Zellen in älteren Personen, konnte diese Population nach in vitro Stimulation mit dem M158–66-Peptid signifikant vergrößert werden. Diese M158–66-spezifische CD8+ T-Zellen produzierten Perforin und hatten einen CD45RO+CD28+CD62L+/− Phänotyp. Unsere Ergebnisse zeigen, dass trotz einer geringen Anzahl M158–66-spezifischer CD8+ T-Zellen bei älteren Personen, diese Zellen nach in vitro Stimulation mit einem Peptid gut expandieren und in Perforin-produzierende Effektor-T-Zellen differenzierbar sind. M158–66-Peptid oder andere immundominante Peptide aus konservierten Influenzaproteinen könnten somit einen wichtigen Bestandteil zukünftiger Influenzaimpfstoffe darstellen um älteren Personen einen verbesserten Schutz vor Influenza zu bieten, insbesondere beim Auftreten einer Influenza Pandemie.
- 1 March 2007
- Published by Springer Nature in Wiener Medizinische Wochenschrift
- Vol. 157 (5-6) , 116-121
Immundominante Peptide von konservierten Influenzaproteinen – Eine Möglichkeit für eine wirksamere Impfung älterer Personen?
Influenza-specific CD8+ T cells are important for the clearance of infection especially in high risk groups such as elderly persons. Activation of these cells by immunization might therefore be a useful tool for a better protection of this specific age group. We therefore analyzed the frequency, phenotype and function of CD8+ T cells with specificity to the influenza M158–66 peptide in young, middle-aged and elderly persons ex vivo and after in vitro stimulation. Significantly lower numbers of M158–66-specific CD8+ T cells were detected in the middle-aged and elderly compared to young donors. M158–66-specific CD8+ T cells were either CD45RAlowCD45ROlow or CD45RA-CD45RO+, expressed CD28 and CD62L and did not produce perforin. There was no difference in the phenotype of influenza-specific CD8+ T cells between the three age groups. Despite the initially low numbers of M158–66-specific CD8+ T cells in the older age groups, these cells could be expanded in vitro following peptide stimulation. They also acquired a CD45RO+CD28+ CD62L+/− phenotype and produced perforin. Our results demonstrate that although initially low in number, M158–66-specific CD8+ T cells from elderly persons can be propagated and differentiated into perforin producing effector cells upon appropriate stimulation. M158–66 peptide or other immunodominant peptides derived from conserved influenza proteins could therefore be useful in future influenza vaccines in order to render elderly persons better protected against disease, in particular in the case of an influenza pandemia. Influenza-spezifische zytotoxische CD8+ T-Zellen stellen einen wesentlichen Bestandteil bei der Überwindung einer Infektion dar, insbesondere in Hochrisikogruppen wie älteren Personen. Eine Aktivierung dieser Zellen durch eine Impfung wäre deshalb eine wichtige Voraussetzung um einen besseren Schutz für diese Altersgruppe zu erreichen. Deshalb haben wir die Häufigkeit, den Phänotyp und die Funktion von Influenza M158–66 Peptid-spezifischen CD8+ T-Zellen in drei verschiedenen Altersgruppen (27 ± 1 Jahre; 46 ± 3 Jahre und 72 ± 2 Jahre) ex vivo und nach in vitro Stimulation untersucht. Bei Personen ab einem Alter von 38 Jahren stellten wir eine geringere Anzahl von M158–66-spezifischen CD8+ T-Zellen fest. Diese Zellen exprimierten CD28, CD62L und waren entweder CD45RAlowCD45ROlow oder CD45RA-CD45RO+, produzierten aber kein Perforin. Kein Unterschied zeigte sich beim Phänotyp von Influenza-spezifischen CD8+ T-Zellen zwischen den drei Altersgruppen. Trotz der zu Beginn geringen Anzahl von M158–66-spezifischen CD8+ T-Zellen in älteren Personen, konnte diese Population nach in vitro Stimulation mit dem M158–66-Peptid signifikant vergrößert werden. Diese M158–66-spezifische CD8+ T-Zellen produzierten Perforin und hatten einen CD45RO+CD28+CD62L+/− Phänotyp. Unsere Ergebnisse zeigen, dass trotz einer geringen Anzahl M158–66-spezifischer CD8+ T-Zellen bei älteren Personen, diese Zellen nach in vitro Stimulation mit einem Peptid gut expandieren und in Perforin-produzierende Effektor-T-Zellen differenzierbar sind. M158–66-Peptid oder andere immundominante Peptide aus konservierten Influenzaproteinen könnten somit einen wichtigen Bestandteil zukünftiger Influenzaimpfstoffe darstellen um älteren Personen einen verbesserten Schutz vor Influenza zu bieten, insbesondere beim Auftreten einer Influenza Pandemie.
- Open Access
- 1 September 2005
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 17 (10) , 1359-1366
Age-related differences in phenotype and function of CD4+ T cells are due to a phenotypic shift from naive to memory effector CD4+ T cells
Based on the combined expression of CD27 and CD28, a putative model of T cell differentiation has been previously proposed. We used CD27 and CD28 expression in order to comparatively study the size, cytokine production capacity and proliferative response of CD4+ T cell sub-populations from healthy young and elderly volunteers. Elderly persons had a lower percentage of CD27+CD28+ but a higher percentage of CD27−CD28+ and CD27−CD28−CD4+ T cells than the young persons. CD27−CD28−CD4+ T cells were present, although at relatively low numbers, in the vast majority of the healthy elderly donors but were only sporadically detected in young persons. Each CD4+ T cell sub-population exhibited a distinct phenotype and cytokine production profile, which were not affected by age. When purified CD27+CD28+ were stimulated by staphylococcal enterotoxin B, they proliferated to a greater extent than CD27−CD28+ and CD27−CD28−CD4+ T cells. However, we did not observe age-related differences in proliferative response of each sub-population. We concluded that although the size of the different sub-populations differed between the young and the old group, the functional characteristics of each sub-population were the same in both age groups. This suggests that on a per cell basis there is no functional impairment of CD4 memory T cells in elderly persons. Consequently, potential differences in the function of the total CD4+ T cell population are most likely due to different composition of repertoire.
- 1 September 2005
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 17 (10) , 1359-1366
Open AccessAge-related differences in phenotype and function of CD4+ T cells are due to a phenotypic shift from naive to memory effector CD4+ T cells
Based on the combined expression of CD27 and CD28, a putative model of T cell differentiation has been previously proposed. We used CD27 and CD28 expression in order to comparatively study the size, cytokine production capacity and proliferative response of CD4+ T cell sub-populations from healthy young and elderly volunteers. Elderly persons had a lower percentage of CD27+CD28+ but a higher percentage of CD27−CD28+ and CD27−CD28−CD4+ T cells than the young persons. CD27−CD28−CD4+ T cells were present, although at relatively low numbers, in the vast majority of the healthy elderly donors but were only sporadically detected in young persons. Each CD4+ T cell sub-population exhibited a distinct phenotype and cytokine production profile, which were not affected by age. When purified CD27+CD28+ were stimulated by staphylococcal enterotoxin B, they proliferated to a greater extent than CD27−CD28+ and CD27−CD28−CD4+ T cells. However, we did not observe age-related differences in proliferative response of each sub-population. We concluded that although the size of the different sub-populations differed between the young and the old group, the functional characteristics of each sub-population were the same in both age groups. This suggests that on a per cell basis there is no functional impairment of CD4 memory T cells in elderly persons. Consequently, potential differences in the function of the total CD4+ T cell population are most likely due to different composition of repertoire.
- 15 March 2005
- Published by American Society for Microbiology in Journal of Virology
- Vol. 79 (6) , 3675-3683
Long-Term Cytomegalovirus Infection Leads to Significant Changes in the Composition of the CD8+T-Cell Repertoire, Which May Be the Basis for an Imbalance in the Cytokine Production Profile in Elderly Persons
In spite of the present belief that latent cytomegalovirus (CMV) infection drives CD8+T-cell differentiation and induces premature immune senescence, no systematic studies have so far been performed to compare phenotypical and functional changes in the CD8+T-cell repertoire in CMV-infected and noninfected persons of different age groups. In the present study, number, cytokine production, and growth potential of naïve (CD45RA+CD28+), memory (CD45RA−CD28+), and effector (CD45RA+CD28−or CD45RA−CD28−) CD8+T cells were analyzed in young, middle-aged, and elderly clinically healthy persons with a positive or negative CMV antibody serology. Numbers and functional properties of CMVpp65495-503-specific CD8+T cells were also studied. We demonstrate that aging as well as CMV infection lead to a decrease in the size of the naïve CD8+T-cell pool but to an increase in the number of CD8+effector T cells, which produce gamma interferon but lack substantial growth potential. The size of the CD8+memory T-cell population, which grows well and produces interleukin-2 (IL-2) and IL-4, also increases with aging, but this increase is missing in CMV carriers. Life-long latent CMV infection seems thus to diminish the size of the naïve and the early memory T-cell pool and to drive a Th1 polarization within the immune system. This can lead to a reduced diversity of CD8 responses and to chronic inflammatory processes which may be the basis of severe health problems in elderly persons.
- 15 March 2005
- Published by American Society for Microbiology in Journal of Virology
- Vol. 79 (6) , 3675-3683
Long-Term Cytomegalovirus Infection Leads to Significant Changes in the Composition of the CD8+T-Cell Repertoire, Which May Be the Basis for an Imbalance in the Cytokine Production Profile in Elderly Persons
In spite of the present belief that latent cytomegalovirus (CMV) infection drives CD8+T-cell differentiation and induces premature immune senescence, no systematic studies have so far been performed to compare phenotypical and functional changes in the CD8+T-cell repertoire in CMV-infected and noninfected persons of different age groups. In the present study, number, cytokine production, and growth potential of naïve (CD45RA+CD28+), memory (CD45RA−CD28+), and effector (CD45RA+CD28−or CD45RA−CD28−) CD8+T cells were analyzed in young, middle-aged, and elderly clinically healthy persons with a positive or negative CMV antibody serology. Numbers and functional properties of CMVpp65495-503-specific CD8+T cells were also studied. We demonstrate that aging as well as CMV infection lead to a decrease in the size of the naïve CD8+T-cell pool but to an increase in the number of CD8+effector T cells, which produce gamma interferon but lack substantial growth potential. The size of the CD8+memory T-cell population, which grows well and produces interleukin-2 (IL-2) and IL-4, also increases with aging, but this increase is missing in CMV carriers. Life-long latent CMV infection seems thus to diminish the size of the naïve and the early memory T-cell pool and to drive a Th1 polarization within the immune system. This can lead to a reduced diversity of CD8 responses and to chronic inflammatory processes which may be the basis of severe health problems in elderly persons.